| Preclinical Stage Projects | Savanna Biotherapeutics, Inc. | Microglia replacement therapy for CSF1R-related Leukoencephalopathy |
$12,993,456 |
| Quest – Discovery Stage Research Projects | Savanna Biotherapeutics, Inc. | Gene-corrected human microglia for the treatment of adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) |
$1,417,948 |
| Conference II | Savanna Biotherapeutics, Inc. | ALSP Community Conference: Insights and Potential of Cell-Based Therapies for the Treatment of Leukodystrophies |
$45,800 |